Nationwide nasal spray recall expands to include another brand as products found to contain mold

A recent nasal spray recall has expanded to another brand, with the Federal Drug Administration saying the products were found to contain mold and unsafe levels of bacteria as customers are urged to “immediately” discontinue using them.

It also comes as health officials say they are “on guard” for what they recently called a “more serious flu season.”

The initial recall, issued earlier this month by MediNatura New Mexico, first applied to one lot of ReBoost Nasal Spray sold nationwide at places like CVS, Walmart and Amazon. In an FDA announcement from Tuesday, MediNatura said the recall now includes all lots of the ReBoost Nasal Spray, along with all lots of ClearLife Nasal Spray.

The expansion of the voluntary recall was initiated due to the company’s “further initiative efforts” and to “ensure customer safety,” the announcement said.

Both homeopathic nasal sprays were distributed to retailers across the country. TheReBoost Nasal Spray, which comes in a white and yellow carton, temporarily relieves nasal congestion, sinus headache and pressure, postnasal drip, sneezing, runny nose, and nasal itching, the FDA said.

According to officials, all lots of ReBoost Nasal Spray that contain an NDC number of 62795-4005-9, a UPC number of 787647 10186 3 and expiration dates between Dec. 2022 and Dec. 2025 are included in the recall.

ClearLife Allergy Nasal Spray is used to temporarily relieve minor allergy symptoms, the FDA said, like sinus pressure, runny or itchy nose, nasal congestion, sneezing, itchy or watery eyes, allergy-related headaches, and itchy throat and skin. According to officials the product comes in a 20ml bottle and is packaged in a green and white carton.

All lots of ClearLife Nasal Spray with an NDC number 62795-4006-9, a UPC number 787647 10188 7 and an expiration between Dec. 2022 and Dec. 2025 are part of the recall, the FDA said.

Both products were found to contain microbial contamination that could be linked to unsafe levels of the Achromobacter bacteria, the FDA said. If the product is used by people who are immuno-compromised, there is “reasonable probability” that adverse health problems or life-threatening infections will occur, the officials said.

The FDA warned that customers should immediately discontinue using the recalled ReBoost and return it to the place of purchase for a full refund.

According to authorities, no reports of adverse events related to the recall have been reported.

In an email to NBC Chicago, MediNatura stressed the product has been on the market for two years with no adverse events reported, and that it was conducting the recall voluntarily and “out of an abundance of caution and care” for customers.